Share on StockTwits

ICU Medical (NASDAQ:ICUI) was downgraded by Zacks from a “neutral” rating to an “underperform” rating in a report issued on Tuesday, Analyst Ratings.Net reports. They currently have a $56.80 target price on the stock. Zacks‘ price objective points to a potential downside of 3.32% from the stock’s previous close.

ICU Medical (NASDAQ:ICUI) traded up 0.36% on Tuesday, hitting $59.00. 180,384 shares of the company’s stock traded hands. ICU Medical has a 1-year low of $53.01 and a 1-year high of $85.00. The stock’s 50-day moving average is $63.58 and its 200-day moving average is $65.78. The company has a market cap of $890.3 million and a P/E ratio of 22.18.

ICU Medical (NASDAQ:ICUI) last announced its earnings results on Wednesday, February 12th. The company reported $0.86 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.73 by $0.13. The company had revenue of $77.90 million for the quarter, compared to the consensus estimate of $84.25 million. During the same quarter last year, the company posted $0.82 earnings per share. ICU Medical’s revenue was down 5.8% compared to the same quarter last year. On average, analysts predict that ICU Medical will post $1.51 earnings per share for the current fiscal year.

Separately, analysts at Roth Capital cut their price target on shares of ICU Medical from $62.00 to $56.00 in a research note on Friday. One research analyst has rated the stock with a sell rating, four have given a hold rating and one has assigned a buy rating to the company’s stock. ICU Medical presently has an average rating of “Hold” and a consensus target price of $64.56.

Manufactures custom-made IV products, such as a click-lock positive connection device, and its accessories.

To view Zacks’ full report, visit

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.